Ad is loading...
NAESX
Price
$118.02
Change
-$1.27 (-1.06%)
Updated
Nov 15 closing price
RTOUX
Price
$43.46
Change
-$0.59 (-1.34%)
Updated
Nov 15 closing price
Ad is loading...

NAESX vs RTOUX

Header iconNAESX vs RTOUX Comparison
Open Charts NAESX vs RTOUXBanner chart's image
Vanguard Small Cap Index I
Price$118.02
Change-$1.27 (-1.06%)
VolumeN/A
CapitalizationN/A
Russell Inv Tax-Managed US Mid&Sm Cap M
Price$43.46
Change-$0.59 (-1.34%)
VolumeN/A
CapitalizationN/A
NAESX vs RTOUX Comparison Chart
Loading...
View a ticker or compare two or three
VS
NAESX vs. RTOUX commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NAESX is a StrongBuy and RTOUX is a Buy.

FUNDAMENTALS
Fundamentals
NAESX has more cash in the bank: 151B vs. RTOUX (1.7B). NAESX pays higher dividends than RTOUX: NAESX (1.31) vs RTOUX (0.18). NAESX was incepted earlier than RTOUX: NAESX (64 years) vs RTOUX (8 years). RTOUX is a more actively managed with annual turnover of: 71.00 vs. NAESX (12.00). RTOUX has a lower initial minimum investment than NAESX: RTOUX (0) vs NAESX (3000). NAESX annual gain was more profitable for investors over the last year : 30.24 vs. RTOUX (26.04). NAESX return over 5 years is better than : 55.43 vs. RTOUX (47.72).
NAESXRTOUXNAESX / RTOUX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence64 years8 years-
Gain YTD15.75811.322139%
Front LoadN/AN/A-
Min. Initial Investment30000-
Min. Initial Investment IRAN/AN/A-
Net Assets151B1.7B8,867%
Annual Yield % from dividends1.310.18723%
Returns for 1 year30.2426.04116%
Returns for 3 years4.660.97483%
Returns for 5 years55.4347.72116%
Returns for 10 years122.58N/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
XPEV12.740.11
+0.87%
XPeng
EPC34.73-0.24
-0.69%
Edgewell Personal Care Company
NVO101.74-3.58
-3.40%
Novo-Nordisk A/S
GLUE7.74-0.74
-8.73%
Monte Rosa Therapeutics
GNLX2.36-0.58
-19.73%
Genelux Corp